Your browser doesn't support javascript.
loading
Discovery and characterization of circulating tumor cell clusters in neuroendocrine tumor patients using nanosubstrate-embedded microchips.
Sun, Na; Yang, Yingying; Miao, Hui; Redublo, Peter; Liu, Hongtao; Liu, Wenfei; Huang, Yen-Wen; Teng, Pai-Chi; Zhang, Ceng; Zhang, Ryan Y; Smalley, Matthew; Yang, Peng; Chou, Shih-Jie; Huai, Kevin; Zhang, Zhicheng; Lee, Yi-Te; Wang, Jasmine J; Wang, Jing; Liang, Icy Y; Zhang, Tiffany X; Zhang, Dongyun; Liang, Li; Weiss, Paul S; Posadas, Edwin M; Donahue, Timothy; Hecht, J Randolph; Allen-Auerbach, Martin S; Bergsland, Emily K; Hope, Thomas A; Pei, Renjun; Zhu, Yazhen; Tseng, Hsian-Rong; Heaney, Anthony P.
Afiliação
  • Sun N; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States; Key Laboratory for Nano-Bio Interface, Suzhou Institute of Nano-Tech and Nano-Bionics, University
  • Yang Y; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Aca
  • Miao H; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Aca
  • Redublo P; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States.
  • Liu H; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States.
  • Liu W; Department of Chemistry and Biochemistry, Department of Bioengineering, Department of Materials Science and Engineering, California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA, 90095, United States.
  • Huang YW; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States.
  • Teng PC; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, United States.
  • Zhang C; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States; Department of Pathology, Southern Medical University, Guangzhou, 510515, Guangdong Province, PR C
  • Zhang RY; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States.
  • Smalley M; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States.
  • Yang P; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States.
  • Chou SJ; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States.
  • Huai K; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States.
  • Zhang Z; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States.
  • Lee YT; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States.
  • Wang JJ; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, United States.
  • Wang J; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States.
  • Liang IY; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States.
  • Zhang TX; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States.
  • Zhang D; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States.
  • Liang L; Department of Pathology, Southern Medical University, Guangzhou, 510515, Guangdong Province, PR China.
  • Weiss PS; Department of Chemistry and Biochemistry, Department of Bioengineering, Department of Materials Science and Engineering, California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA, 90095, United States.
  • Posadas EM; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, United States.
  • Donahue T; Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States.
  • Hecht JR; Department of Medicine, Division of Hematology Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States.
  • Allen-Auerbach MS; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States.
  • Bergsland EK; Department of Clinical Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, 94158, United States.
  • Hope TA; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, 94158, United States.
  • Pei R; Key Laboratory for Nano-Bio Interface, Suzhou Institute of Nano-Tech and Nano-Bionics, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Suzhou, 215123, PR China. Electronic address: rjpei2011@sinano.ac.cn.
  • Zhu Y; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States. Electronic address: yazhenzhu@mednet.ucla.edu.
  • Tseng HR; California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States. Electronic address: hrtseng@mednet.ucla.edu.
  • Heaney AP; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, United States. Electronic address: aheaney@mednet.ucla.edu.
Biosens Bioelectron ; 199: 113854, 2022 Mar 01.
Article em En | MEDLINE | ID: mdl-34896918

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Técnicas Biossensoriais / Tumores Neuroendócrinos / Células Neoplásicas Circulantes Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Técnicas Biossensoriais / Tumores Neuroendócrinos / Células Neoplásicas Circulantes Idioma: En Ano de publicação: 2022 Tipo de documento: Article